TEVA-LAMOTRIGINE DIN 02248232
Health Canada record
| Active ingredient(s) | LAMOTRIGINE 25 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N03AX09 LAMOTRIGINE |
| Original market date | 16-Jan-2004 |
| Current status date | 30-Jul-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Teva Canada Limited — licence 101810, currently licensed, last inspection rating C (2025-03-04).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing LAMOTRIGINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02543710 | AG-LAMOTRIGINE | ANGITA PHARMA INC. | Tablet | LAMOTRIGINE 25 MG | Marketed |
| 02543729 | AG-LAMOTRIGINE | ANGITA PHARMA INC. | Tablet | LAMOTRIGINE 100 MG | Marketed |
| 02543737 | AG-LAMOTRIGINE | ANGITA PHARMA INC. | Tablet | LAMOTRIGINE 150 MG | Marketed |
| 02245209 | APO-LAMOTRIGINE | APOTEX INC | Tablet | LAMOTRIGINE 100 MG | Marketed |
| 02245210 | APO-LAMOTRIGINE | APOTEX INC | Tablet | LAMOTRIGINE 150 MG | Marketed |
| 02245208 | APO-LAMOTRIGINE | APOTEX INC | Tablet | LAMOTRIGINE 25 MG | Marketed |
| 02381362 | AURO-LAMOTRIGINE | AURO PHARMA INC | Tablet | LAMOTRIGINE 100 MG | Marketed |
| 02381370 | AURO-LAMOTRIGINE | AURO PHARMA INC | Tablet | LAMOTRIGINE 150 MG | Marketed |
| 02381354 | AURO-LAMOTRIGINE | AURO PHARMA INC | Tablet | LAMOTRIGINE 25 MG | Marketed |
| 02542757 | JAMP LAMOTRIGINE | JAMP PHARMA CORPORATION | Tablet | LAMOTRIGINE 150 MG | Marketed |
| 02542730 | JAMP LAMOTRIGINE | JAMP PHARMA CORPORATION | Tablet | LAMOTRIGINE 25 MG | Marketed |
| 02542749 | JAMP LAMOTRIGINE | JAMP PHARMA CORPORATION | Tablet | LAMOTRIGINE 100 MG | Marketed |
| 02142082 | LAMICTAL | GLAXOSMITHKLINE INC | Tablet | LAMOTRIGINE 25 MG | Marketed |
| 02142104 | LAMICTAL | GLAXOSMITHKLINE INC | Tablet | LAMOTRIGINE 100 MG | Marketed |
| 02142112 | LAMICTAL | GLAXOSMITHKLINE INC | Tablet | LAMOTRIGINE 150 MG | Marketed |
| 02240115 | LAMICTAL | GLAXOSMITHKLINE INC | Tablet | LAMOTRIGINE 5 MG | Marketed |
| 02243803 | LAMICTAL | GLAXOSMITHKLINE INC | Tablet | LAMOTRIGINE 2 MG | Marketed |
| 02343029 | LAMOTRIGINE | SANIS HEALTH INC | Tablet | LAMOTRIGINE 100 MG | Marketed |
| 02428229 | LAMOTRIGINE | SIVEM PHARMACEUTICALS ULC | Tablet | LAMOTRIGINE 150 MG | Marketed |
| 02428210 | LAMOTRIGINE | SIVEM PHARMACEUTICALS ULC | Tablet | LAMOTRIGINE 100 MG | Marketed |
| 02428202 | LAMOTRIGINE | SIVEM PHARMACEUTICALS ULC | Tablet | LAMOTRIGINE 25 MG | Marketed |
| 02343037 | LAMOTRIGINE | SANIS HEALTH INC | Tablet | LAMOTRIGINE 150 MG | Marketed |
| 02343010 | LAMOTRIGINE | SANIS HEALTH INC | Tablet | LAMOTRIGINE 25 MG | Marketed |
| 02302985 | LAMOTRIGINE-100 | PRO DOC LIMITEE | Tablet | LAMOTRIGINE 100 MG | Marketed |
| 02302993 | LAMOTRIGINE-150 | PRO DOC LIMITEE | Tablet | LAMOTRIGINE 150 MG | Marketed |
| 02302969 | LAMOTRIGINE-25 | PRO DOC LIMITEE | Tablet | LAMOTRIGINE 25 MG | Marketed |
| 02265494 | MYLAN-LAMOTRIGINE | MYLAN PHARMACEUTICALS ULC | Tablet | LAMOTRIGINE 25 MG | Marketed |
| 02265508 | MYLAN-LAMOTRIGINE | MYLAN PHARMACEUTICALS ULC | Tablet | LAMOTRIGINE 100 MG | Marketed |
| 02265516 | MYLAN-LAMOTRIGINE | MYLAN PHARMACEUTICALS ULC | Tablet | LAMOTRIGINE 150 MG | Marketed |
| 02376636 | DOM-LAMOTRIGINE | DOMINION PHARMACAL | Tablet | LAMOTRIGINE 25 MG | Cancelled Pre Market |
| 02376644 | DOM-LAMOTRIGINE | DOMINION PHARMACAL | Tablet | LAMOTRIGINE 100 MG | Cancelled Pre Market |
| 02376652 | DOM-LAMOTRIGINE | DOMINION PHARMACAL | Tablet | LAMOTRIGINE 150 MG | Cancelled Pre Market |
| 02142120 | LAMICTAL - TAB 200MG | GLAXO WELLCOME INC. | Tablet | LAMOTRIGINE 200 MG | Cancelled Post Market |
| 02334577 | NU-LAMOTRIGINE | NU-PHARM INC | Tablet | LAMOTRIGINE 100 MG | Cancelled (Unreturned Annual) |
| 02334585 | NU-LAMOTRIGINE | NU-PHARM INC | Tablet | LAMOTRIGINE 150 MG | Cancelled (Unreturned Annual) |
| 02334569 | NU-LAMOTRIGINE | NU-PHARM INC | Tablet | LAMOTRIGINE 25 MG | Cancelled (Unreturned Annual) |
| 02330946 | PHL-LAMOTRIGINE | PHARMEL INC | Tablet | LAMOTRIGINE 150 MG | Cancelled Pre Market |
| 02330938 | PHL-LAMOTRIGINE | PHARMEL INC | Tablet | LAMOTRIGINE 100 MG | Cancelled Pre Market |
| 02330903 | PHL-LAMOTRIGINE | PHARMEL INC | Tablet | LAMOTRIGINE 25 MG | Cancelled Pre Market |
| 02246898 | PMS-LAMOTRIGINE | PHARMASCIENCE INC | Tablet | LAMOTRIGINE 100 MG | Dormant |
| 02246897 | PMS-LAMOTRIGINE | PHARMASCIENCE INC | Tablet | LAMOTRIGINE 25 MG | Dormant |
| 02246899 | PMS-LAMOTRIGINE | PHARMASCIENCE INC | Tablet | LAMOTRIGINE 150 MG | Dormant |
| 02243353 | RATIO-LAMOTRIGINE | TEVA CANADA LIMITED | Tablet | LAMOTRIGINE 100 MG | Cancelled Post Market |
| 02246963 | RATIO-LAMOTRIGINE | TEVA CANADA LIMITED | Tablet | LAMOTRIGINE 150 MG | Cancelled Post Market |
| 02243352 | RATIO-LAMOTRIGINE | TEVA CANADA LIMITED | Tablet | LAMOTRIGINE 25 MG | Cancelled Post Market |
| 02248234 | TEVA-LAMOTRIGINE | TEVA CANADA LIMITED | Tablet | LAMOTRIGINE 150 MG | Cancelled Post Market |
| 02248233 | TEVA-LAMOTRIGINE | TEVA CANADA LIMITED | Tablet | LAMOTRIGINE 100 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 11884 | 2010-11-25 | Abbreviated New Drug Submission (ANDS) | Manufacturer and product name change |
| 1514 | 2003-11-13 | Abbreviated New Drug Submission (ANDS) |
International API supply for LAMOTRIGINE
16 valid EDQM Certificates of Suitability from 16 holders. 26 active FDA Drug Master Files.
Request a quote for TEVA-LAMOTRIGINE